{"ticker": {"uuid": "7d80bd89-9e6b-4793-b5cb-2552f2f8f3af", "symbol": "ADVB", "name": "Advanced Biomed Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Qiagen stock holds steady as diagnostics demand shapes long term outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQelQ5VFNlelhIMTJsZk10QUwxRE5sNFBOdEVJVVdSdHVFaS03NjJTXzE1NUZxNUJVUDB1a1k2VFlpM3IzYjFxX3dkVFg5UkxfRGt1Nl8takZ6Y0NSLWFHRzlIeFFwVnhHYlktNUIzN3JGZlZ6OUxwQlo3T1ZGUVJ4T2tXMnlzUlA1UVpoMFFpVlhxTlZhUTRUVWI2WjZRZHFIRHp4R0MyZE53SWI1Tk9KRmg0T3c2QkhnWEw3dDFXZXFCNTVpdDJJWVBHQQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-14T09:00:58+00:00", "published_display": "14 Jul 2026 09:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "The article concerns the number of shareholders for Advanced Biomed Inc. (NASDAQ: ADVB). It is a brief entry from TradingView, which also provides additional financial and market data, tools, and community features related to stock trading and analysis.", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-07-13T13:40:55", "published_display": "13 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYXRxTGlQaFZybjJ5a2J0WHl5bXp5QTRPMS1vTG5XVUoyU3Z4ZlRiSnUtRTQ2TWF4dG9FSzkwYmRYcnhDZUFqXzVuSTdFVEg1eVU0TXBNS2k0V2xEdm9MR3lzNTlCMzN3UEpMNmppZTlfbEZRWGloRm84VjllY0dtTUNMM3pCZFdyVUlPaS1saXdOOU1OVzVDa29zRURQZXlsRVZ6M3pITWVVSmVyQXZpSXIwWGxyaWxQZ1VNRTgwRGo4RndMZEE2MERVZlQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-13T06:08:44+00:00", "published_display": "13 Jul 2026 06:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOT0p5UGpYTGw0d1loeEdBbndGeFltLXVyMWdtWFl1eXYydnhXancxcnpWMUJvN3Y0RWxFTmljekw4b3BERndMUUduUW8xQUY3TktkRV9TOS1PcHJmaFNrV01pVWkzQzJJbG9fWjhUN0FDS2Vqa3JmenB2ellkUHZiMl9DRkJBbUNKcm85RndRd2tkU1dMLU5rRl9CNVZPQ1p6T1VkOF9OTEZoVDJKNi0xVDRjajNXVTA0eFVVY0RrWXQwS2M?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-12T12:19:06+00:00", "published_display": "12 Jul 2026 12:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche stock holds steady as pharma giant leans on diagnostics and oncology strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPa0hsdjNPUWxBTFVtcXYyOUpSbnB0WnpoR1k5c1EyaFVPOXJmR0NROGpoazIwMC1FWFFiYmh4VGl5ZkZHbEFtNXNBalBIbTY5Q29aSXdNTkpiNEU4ZDdIZHJ2SjNoYjRqaHBLdUNSYTBieUhEdHBzc1V0UFQ3QkxPZ0s0d2pSWWhid3pOQW5uMUVHRmRpQmpCa0FkY2hrVHM4c2ViTFRWOWpLVkY2NWpBM0FuMkFDZWlUaG5ncWl4ckxNeENDMjhHWVpUSG8xUQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-11T08:31:21+00:00", "published_display": "11 Jul 2026 08:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "This article provides the \"Price to book forward\" for Advanced Biomed Inc. (NASDAQ: ADVB) as listed on TradingView. It indicates that the market was closed at the time of viewing, with no trades having occurred. The content primarily features navigation links and disclaimers rela", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T17:39:58", "published_display": "08 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Labcorp stock holds its business focus. Clinical diagnostics remain the core.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTEN6RDNESkFmZDlqelJTb2V5b2txajhDRHJVd3RmR01BT0VyVjdvdllJMEZtNzRkQ0VyekhNU2Z4V0Q3S29SWXBtTndrSHpmcGQ3TzRyZW8wXzI1NzVoV1UtT1JpbDJJMmo2TXdBNy1EX2NOVlgzZ1lERmlyYThrSmJIcGVrQkVJa3lJLTFRSV9EUWhocDc5cWU1MjFEVGxJRWtCVE8yQkloZHVCTGV0SjVucktQSEJUSVJTZzdhUGFwVnVNNnA4Zg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-08T09:51:39+00:00", "published_display": "08 Jul 2026 09:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "This article briefly mentions the \"Price to earnings forward\" metric for Advanced Biomed Inc. (NASDAQ: ADVB). It appears to be a stub or a section from a financial data platform, providing minimal direct information beyond the company name and stock ticker.", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T04:11:20", "published_display": "08 Jul 2026 04:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "The article focuses on the \"Price to sales forward\" metric for Advanced Biomed Inc. (NASDAQ: ADVB). It appears to be a stub or a section of a larger financial analysis tool, likely from TradingView, providing only a heading for this specific financial data point. No actual values", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T23:10:21", "published_display": "06 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "This article provides financial data for Advanced Biomed Inc. (NASDAQ: ADVB), focusing on its enterprise value to EBIT forward. It indicates that the market was closed at the time of publication with no trades, and the content is primarily a data placeholder from TradingView.", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T20:40:35", "published_display": "06 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Labcorp stock holds steady as investors watch the next filing cycle", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQNWV5dmpPWEZCYU5NSU0xbHNGMnp5LVYzT05raVVRblI2UF9nZHBGSVZlSkRORVNEVkltRkFXdEtMWnhkaDVLUWFfdVZIak1xSlZMZTZDbldvQ0dnYm9ZenF5elVOUjR6dDlCakFXOXh0bERqeTNHRzdkNHQzZmdGaU9uR0ktZEhBYm9jNTB1VExfVktFal82c1ZKcnBLQVJ3WkwzWVQtRWk3Y3liMGt6cU1SNThsX2o4a1NsZVk1UDVmLW40?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-04T08:31:51+00:00", "published_display": "04 Jul 2026 08:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (NASDAQ: ADVB) investors approve all 2026 meeting proposals", "summary": "Advanced Biomed Inc. (NASDAQ: ADVB) stockholders approved all five proposals at their annual meeting on June 30, 2026. These approvals included the election of five directors, a non-binding endorsement of executive compensation, annual advisory votes on pay, and the ratification ", "url": "https://www.stocktitan.net/sec-filings/ADVB/8-k-advanced-biomed-inc-reports-material-event-8ec3f8197919.html", "source_name": "Stock Titan", "published_at": "2026-07-02T08:41:03", "published_display": "02 Jul 2026 08:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. 8-K Filing: Company Details, Emerging Growth Status, and Nasdaq Listing for 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNcXVEOVZHZzlYekItZ21IRHQyTElZR25OcmY2NFhBZjlFSUI1aUJXekNPQVdzV2VkMnVrWFBRblVtZzN2amhYUFc5aUZxU1hraU1FUWdTYW5wejNTLU0xU3VvZjUxQ0ZucDRuaFhTU2xJV0Zzd3BUMDRFQW1QQ0MwR3BDZG5Dbi1uQTdlRGVsSl9hcGxSdXRoV09FSlA0T2EwVXplTGFKSFVQam1xMTdWMGVHVzExRkpGendPMWdyUzJsa0oweVM4cGRMbDJHWkJIdk52cg?oc=5", "source_name": "Minichart", "published_at": "2026-07-02T00:57:00+00:00", "published_display": "02 Jul 2026 00:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADVB - Advanced Biomed Inc Earnings", "summary": "This article provides a detailed financial overview of Advanced Biomed Inc (ADVB), including its last close price, market capitalization, earnings per share, and other key financial ratios and performance metrics. It lists short interest, insider and institutional ownership, prof", "url": "https://finviz.com/stock?t=ADVB&ty=ea&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-02T00:39:26", "published_display": "02 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (NASDAQ: ADVB) selling Taiwan R&D subsidiary for $490K", "summary": "Advanced Biomed Inc. (NASDAQ: ADVB) is selling its wholly-owned Taiwan R&D subsidiary, which focuses on biomedical research and development and the A+PerfusC 3D cell culture platform, for $490,000 to an unrelated third party. The transaction, reported in an 8-K filing, is expecte", "url": "https://www.stocktitan.net/sec-filings/ADVB/8-k-advanced-biomed-inc-reports-material-event-6540cd9f5d95.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:38:59", "published_display": "01 Jul 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed - To Sell Taiwan Subsidiary For $490,000 - SEC Filing", "summary": "Advanced Biomed (ADVB) has announced its intention to sell its Taiwan subsidiary for $490,000, according to a recent SEC filing. This information was reported by Refinitiv.", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN4320WI:0-advanced-biomed-to-sell-taiwan-subsidiary-for-490-000-sec-filing/", "source_name": "TradingView", "published_at": "2026-07-01T08:39:00", "published_display": "01 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed to Divest Taiwan Subsidiary for $490,000; Closing Expected Within Three Months", "summary": "Advanced Biomed (ADVB) has entered into a Share Purchase Agreement to sell its Taiwan subsidiary for $490,000 to an unrelated third party. This divestiture includes its biomedical R&D operations and the A+PerfusC 3D cell culture platform. The move is aimed at refocusing the compa", "url": "https://www.tradingview.com/news/tradingview:07d989e53c9ff:0-advanced-biomed-to-divest-taiwan-subsidiary-for-490-000-closing-expected-within-three-months/", "source_name": "TradingView", "published_at": "2026-07-01T08:38:59", "published_display": "01 Jul 2026 08:38", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. Sells Taiwan Subsidiary for $490,000 in Share Purchase Agreement \u2013 Nasdaq: ADVB 8-K Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQWHdxYkQ2ckNRUTJnVUxWdTdzRzc1Tk1zdWxZRVNxM2VoemdYdm9TdXhJTjlHb2p2WlhKMlhLbVBLQW95ckNPa3BjVHFmem16RzlXTkRSZ2Z2VFpjdkI2TUJkUmdqWW5GLUtBbzdQYzVacWpVVEh6M2ZJNkpZWlhEV1dCRVdxc3lDR0FUSnBwanhMbjVTRTI0a2tTcU1BRjRNeTRVLU9SNTBIRTRXNTZkazlES0Z3alRkcGNzMGw0dHJ1em1GZE9SWmQwQlNIa2J6NTgzTDhmdDNnYmNYVGdB?oc=5", "source_name": "Minichart", "published_at": "2026-07-01T00:37:00+00:00", "published_display": "01 Jul 2026 00:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed | 10-Q: Q2 2026 Earnings Report", "summary": "This document is the 10-Q filing for Advanced Biomed's Q2 2026 earnings report. Further details about the financial performance for the quarter would be contained within the omitted content of this document. It serves as an official report to the SEC regarding the company's finan", "url": "https://www.moomoo.com/news/notice/306495190/advanced-biomed-10-q-q2-2026-earnings-report", "source_name": "Moomoo", "published_at": "2026-06-28T21:39:27", "published_display": "28 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Miaozhu Zhao entered into a Share Purchase Agreement to acquire Advanced Biomed Inc. from Advanced Biomed Inc. for $0.49 million.", "summary": "Miaozhu Zhao has entered into a Share Purchase Agreement to acquire Advanced Biomed Inc. for $0.49 million. The transaction is expected to be completed within three months from the agreement date of June 30, 2026. This acquisition involves a cash consideration paid towards the co", "url": "https://www.marketscreener.com/news/miaozhu-zhao-entered-into-a-share-purchase-agreement-to-acquire-advanced-biomed-inc-from-advanced-b-ce7f5edede80f52c?utm_source=copy&utm_medium=social&utm_campaign=share", "source_name": "marketscreener.com", "published_at": "2026-06-28T00:10:00", "published_display": "28 Jun 2026 00:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent (A) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOQ3dIcEY1SVlJRzRVdm1YbDVMRTdody00UzB0OUhFQVhvenJBNERmNDlBbmZMMEZETzJaeVZfekJvYm9lYkVTdl8tbllZbUcxN1poZmFqX0I2ZXFzUE8zdV9TWlFUSXJUbkhDMFoxOW43amQyX1NzanNIZHI3YVFaZ1VkX1NqLTE0X3REem5paUVEc2dUMzJWSUtLVFhybm8?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Advanced Biomed Inc (ADVB), detailing its support, resistance, and key technical indicators. It presents a summary of various indicators like MACD, RSI, KDJ, and Moving Averages, which collectively suggest a \"Sell\" signal for the stoc", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/technical", "source_name": "TradingKey", "published_at": "2026-06-23T07:10:32", "published_display": "23 Jun 2026 07:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Labcorp Stock - Analyst and consensus view at the start of the week", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOcFVnd0dMT1ZYZFNld2dWaFF1T0Nic0dhemw1RmgyT2lmNlNJcmJWaDJyMVBfdXZsdHdObTRtQ2VkR25wMDBFSGk3c1lhLVZUVjB0MVU3eFJEM1V4OEZibmlRdTh0aTJNS3gtUURqV1RRRU5PN0lKandzUG1WYUYtTGpPS1VqMEF4U3MxTS13RGtzY2VuaXY0U0IwcUVYR2lkTzRfRmU4LWFyMDF5SGtvM2xjYkdKaWphLUlnTERLa1FkUQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thermo Fisher Stock - Analyst consensus and Sunday background", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVmxRNF9RX1BLajBmaXpRTU0wWWJOYUJKQWJmQWNHMnBaZ2EzQTBiUV9jVWgwT05WMlhDQUhCeXFwQnhHTjIxRjRzekpQbDBBMktiUjlqaTVlVHA4M3I5WnRPQUNSREs4MGs0MXFnb2VXVVF0djZjR3VMaEtsV3VJbzVONEp4eXl0NGRsWkQ2REtLSy1pbEVnSS13UXV6MHBEcjduTGE2cDNhZUFCQ3pEY1VXbE5wc0RIOWc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Stock - long-term strategy in life sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTHdqczJiTzgxU2VwYnowLXhoanpKY0ZWX0dvMHF0OHc0NmJnREJPNmRCOTFNVUhjWkY2RTdaUklONUpxRC1qaG9rMG9Jbi1vTkhTM3NzbUljYUstUFdwejEtZWhMd2Y1UVZ1azRqTGpRbVM5SFZ4RENHeUdWZ3Y0NDdQWjd0czhPaHZ3Si1CSjQ2NlpOdWM0V19RUUw5dGV5a2ZSaklsbi1yc1pJ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Stock - Analyst targets, sector review and weekly recap", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONXVEeDZuTjZDaXh0dnlqY0NPTENZX0c4cFBxSDV3UWh1NC1XMU9ialR4Wk5TbnlpRVpXU05EVENEYjAtcGpoZmR2TVhLandUM0tIS2V4Rmk0dDZJMk44bm9tbl9SRUwtcGNLOXBGOGp4WlNpeE1aY0ZwRDdEZzB2NDhhUXFCV0p1MFB2djBnaDdfREtqMmhHcTFFMHIwcy1qOURxR2c2QTQzTkNsczZqbklmb0h2WlE5OE51cUlZU0VyY2ZMeUpHVw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-19T16:09:41+00:00", "published_display": "19 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bachem Stock - Analyst consensus and pipeline focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPejRJd3VQMzAtWnQwMUFQcnVfaEtOLThKODlKYjVITHRmNlh5Wi05T2xNWDQ0Q0piSkMydFcxaUpjWHJCc080LU1iZjEwaWxnX1RRYkFqX2tFdXQ1N0pqcWRKT1BQcmdtTkN1R2tDRlVmWjEzMG5kYjllQmpFN3pvT2JaRzNYVlVmd085SmlNNVpmaDBuU0lnMEUxOHdpTTlvTkpCcWk1SEp3MWZD?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-18T20:19:53+00:00", "published_display": "18 Jun 2026 20:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Institutional Confidence", "summary": "This article provides details on the institutional confidence in Advanced Biomed Inc (ADVB), including shareholder activity and the number of shares held by key individuals and firms. It shows that while some individual holders maintain significant positions, institutional holder", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T11:40:43", "published_display": "18 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a brief overview of Advanced Biomed Inc (ADVB) valuation metrics, including its current stock price, market cap, and P/E TTM. It notes that key valuation data such as P/E, P/B, P/S, and P/CF have not yet been disclosed by the company. The page appears to be ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T11:40:43", "published_display": "18 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Advanced Biomed Inc (ADVB), focusing on future EPS and revenue growth estimates. It notes that relevant data for financial forecasting, including EPS, revenue, net profit, and EBIT, has not yet been disclosed by the company. The info", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T11:40:43", "published_display": "18 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides a detailed historical overview of dividends and stock splits for Advanced Biomed Inc (ADVB). It notes that the company has not distributed any dividends in the past five years and lists one upcoming stock split event: a 20-for-1 merger scheduled for January ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T02:39:47", "published_display": "18 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey reports on Advanced Biomed Inc (ADVB) and its revenue breakdown. However, it notes that key relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page provides basic stock ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T21:39:47", "published_display": "17 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (NASDAQ: ADVB) details 2026 votes and AI-focused acquisition", "summary": "Advanced Biomed (NASDAQ: ADVB) has detailed the agenda for its June 30, 2026, annual shareholder meeting, which includes electing directors, approving executive compensation, and ratifying auditors. The company highlighted recent strategic changes, including the appointment of Xi", "url": "https://www.stocktitan.net/sec-filings/ADVB/def-14a-advanced-biomed-inc-definitive-proxy-statement-c4f193386b1e.html", "source_name": "Stock Titan", "published_at": "2026-06-04T21:39:28", "published_display": "04 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Stock Inches Up Before Nasdaq Opens As AI Pivot Faces Its First Real Tests", "summary": "Advanced Biomed Inc. (NASDAQ:ADVBI) saw its shares rise before the Nasdaq session opened on Wednesday, following an announcement of a strategic pivot from life sciences to AI development. The company recently acquired Acellent Technologies (Hong Kong) and appointed Xiaomin Chen a", "url": "https://www.bez-kabli.pl/advanced-biomed-stock-inches-up-before-nasdaq-opens-as-ai-pivot-faces-its-first-real-tests/", "source_name": "Bez Kabli", "published_at": "2026-06-03T07:14:00", "published_display": "03 Jun 2026 07:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Company Profile & Introduction", "summary": "This document provides a company profile and introduction for Advanced Biomed. It details key information about the company's operations and objectives within the biomedical sector. The report aims to give a comprehensive overview for stakeholders interested in the company's back", "url": "https://www.moomoo.com/stock/ADVB-US/company?chain_id=Name1K9-3FXPhg.1l04rc0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A107,%22f%22%3A%22www.moomoo.com%2Fetfs%2FSGOL-US%22%7D", "source_name": "Moomoo", "published_at": "2026-06-02T13:09:32", "published_display": "02 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed(ADVB) Stock Options Chain | Quotes & News", "summary": "This page from Moomoo provides detailed stock information for Advanced Biomed (ADVB), including its options chain, real-time quotes, and key financial data. It also lists market insights and trending ETFs, along with legal disclosures regarding the risks of investing and options ", "url": "https://www.moomoo.com/stock/ADVB-US/options-chain?chain_id=Name1K9-3FXPhg.1l04rc0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A107,%22f%22%3A%22www.moomoo.com%2Fetfs%2FSGOL-US%22%7D", "source_name": "Moomoo", "published_at": "2026-05-30T09:10:49", "published_display": "30 May 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADVB - Advanced Biomed Inc Stock Price and Quote", "summary": "This article provides a detailed overview of Advanced Biomed Inc (ADVB) stock, including its latest close price, key financial metrics, performance indicators, and recent news announcements. It covers financial data like market cap, income, P/E ratio, and insider ownership, along", "url": "https://finviz.com/stock?t=ADVB", "source_name": "Finviz", "published_at": "2026-05-29T19:41:05", "published_display": "29 May 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADVB Stock Chart | ADVANCED BIOMED INC (NASDAQ:ADVB)", "summary": "This page provides a stock chart for ADVANCED BIOMED INC (NASDAQ:ADVB), displaying its current stock price and recent performance. Users can view daily, weekly, or monthly charts with various display options. The site offers tools for technical and fundamental analysis, along wit", "url": "https://www.chartmill.com/stock/quote/ADVB/stock-chart", "source_name": "ChartMill", "published_at": "2026-05-29T19:39:54", "published_display": "29 May 2026 19:39", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (ADVB) Earnings Date and Reports 2026", "summary": "Advanced Biomed (ADVB) announced its Q3 2026 earnings on May 15, 2026, reporting an EPS of -$0.38 against a consensus estimate of -$0.38. The company currently has a trailing EPS of $4.82 and a P/E Ratio of 0.82. Investors can sign up for alerts to stay updated on future earnings", "url": "https://www.marketbeat.com/stocks/NASDAQ/ADVB/earnings/", "source_name": "MarketBeat", "published_at": "2026-05-22T16:10:55", "published_display": "22 May 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. 10-Q Summary: Net income $5.98M, EPS $5.21\u2014 10-Q Summary", "summary": "Advanced Biomed Inc. reported a significant improvement in its financial performance for the nine months ended March 31, 2026, with a net income of $5.98M and diluted EPS of $5.21, compared to a net loss in the prior year. The company has made progress in product development and ", "url": "https://www.tradingview.com/news/tradingview:77fa167d93e9d:0-advanced-biomed-inc-10-q-summary-net-income-5-98m-eps-5-21-10-q-summary/", "source_name": "TradingView", "published_at": "2026-05-15T13:38:55", "published_display": "15 May 2026 13:38", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thermo Fisher Scientific stock (US8835561023): Q1 earnings beat with EPS of $5.44", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPbmxEX0RGdkI4NjVZUmItT1hobEdHaFl6dUVwQm01aGRIWW5zTnpWbUY5bVpPQWF1OW9OVVczMy1ReWdxTHJ3RXktOEdNY3lIUjdhUnV4enY0aTJVN2VWX01CbW9qWU51dDFRU1g1c21MU0c4MHBCYnBiZ00xeGRvVmkxVjdWSk8xeFhrRnpuek05azZRT1Z0bV8ya1Mzd0l4bHp0MHF4V1pzelVNTkVXVTVBVE8xeW9saElxTzdzbndfTEhEcjFr?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TWST Stock Forecast: Anticipated Revenue of $438.75M with Strong Margins", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQTTE2UVJHTkZNZFNYQ3NWeDlZdksxUG9nU0ZSVkFQVUZTZUU5QmNnZkJOYkd2TkVybjc4MHFCcXcyNWV4b3NDRnViOVVDc0RxSEM4MUN0NDNzTnctLTBsWkt1SFdBaUZfY0tYeFBHRXBpYlRzMHEwRGlYelRqU0V4cEhRU2VhSVh2dzRtaE9Ebi15bUd0Q0RNclRVN1ExYWttOUtnVnVfYUY3bjNlMUR6WDFXUHN0U2FWZV93Yw?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. completed the acquisition of Acellent Technologies (Hong Kong) Co. Limited from Xiaomin Chen.", "summary": "Advanced Biomed Inc. (NasdaqCM:ADVB) has completed the acquisition of Acellent Technologies (Hong Kong) Co. Limited from Xiaomin Chen for $1.2 million. The acquisition, which was conditioned on due diligence and regulatory approvals, was finalized on April 30, 2026. Advanced Biom", "url": "https://www.marketscreener.com/news/advanced-biomed-inc-completed-the-acquisition-of-acellent-technologies-hong-kong-co-limited-from-ce7f5bdbda8bf027", "source_name": "www.marketscreener.com", "published_at": "2026-05-03T22:11:13", "published_display": "03 May 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Completes AI Acquisition and Leadership Transition", "summary": "Advanced Biomed Inc. (ADVB) has acquired Acellent Technologies (Hong Kong) Co. Limited for $1.08 million in an all-stock deal, pivoting its business from life sciences to AI for financial markets. This strategic shift includes the departure of CEO Yi Lu and the appointment of Xia", "url": "https://www.tipranks.com/news/company-announcements/advanced-biomed-completes-ai-acquisition-and-leadership-transition", "source_name": "TipRanks", "published_at": "2026-05-01T22:40:24", "published_display": "01 May 2026 22:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADVB Stock Soars Amid Strong Financial Performance and Strategic Milestones", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPMFdOLWtVQjcyRDB2U0o4WTVxTzNKaWJJNmVaUmRWV3NFRldUYVJqaE0xNldBU0FmWjVINjFna3h5RnBOa0JZbWZYd21XaUowWDF4eG9lV2ROc2M1UUo3RGNLR1RKMllOMXAtMmstQ0hpdmdzYkxnVHhhRnBwNTJoeg?oc=5", "source_name": "timothysykes.com", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Natera's Recent Stock Action", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQdUptOV9abnB2R3daZE82Sm16ZnBLY3I2bWo1Nk9ZZ3M0U2FJYUQyNFFnM09UQzBSaWQ4c0tnSnp1S01Wa00tYnhfbGNoc1BtcXh2MWhYY09zZG5zSkJsSWFaaTZZSnJ4UC1YLWgzRTlqaXh5MU5vOG9ybUpWTG14eS11Z2Q?oc=5", "source_name": "Kavout | AI", "published_at": "2026-03-17T04:42:02+00:00", "published_display": "17 Mar 2026 04:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. Announces 1 for 20 Share Consolidation", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQckNfUXgtNEF6THBXdE5RVUhrQkJTeTFzYWxnbHdZMWRNSWx2OWg3MExIWmZuaDFvekJXc3dFNVlleXo3Q29JTFB6VkdSRkRteElnZVhrdGE3a09NbkFoYXVhbEw1X2pNMXZoa1BTUHFIY2YxOV9rbFZXdlpOcU1IbUhDMA?oc=5", "source_name": "Market source", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (ADVB) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9vVWx0bDdoNHlRZDRIQkZHSml3Q05sYUhQVDJBVEZ2MDJUVFF6OW5HYjdSYU5fbmRCT0J0WHJpN05kazJkN2Y0bUFsVU83MjNRbzloaWluVjRMT21FU2FyWU9OM3J2dw?oc=5", "source_name": "MarketBeat", "published_at": "2026-01-28T04:32:08+00:00", "published_display": "28 Jan 2026 04:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (ADVB) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE1ld0dpbHBDbDM0VEJlaS1hdUNjRzNCcmh0TVd1VVRhXzBLVHpmVWJyWTdFNDFSa3Ita1Rxb3kzUkRsWVAxTkRHUGZjbjFDTzVOeWJvUDBhcF9idw?oc=5", "source_name": "MarketBeat", "published_at": "2026-01-28T04:32:07+00:00", "published_display": "28 Jan 2026 04:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mainz Biomed NV (MYNZ) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1tRFFLUWNOZnpFTzhEazgyejF6dWszZTFBaTd4Ujh2QWxzRUczYUhIT0lZQUlOR3RqSnJrb2h3OUYxYk50V3A4NkllMGQ0SnE0dkRB?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:00:43+00:00", "published_display": "25 Apr 2025 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "bioAffinity Tech (BIAF) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBuOHNESDRoUTBXSmRReFY0aUwxZ1FRa1REcXJkMmVqbFRYN1d6Q216M3NMRFluQ200eHRSTk81ZWdkajZPLWVEaEFSMFlHRmxGLUZr?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T20:37:30+00:00", "published_display": "24 Apr 2025 20:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XWELL (XWEL) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5Yd2VxUDJhMHRobmFmV0pUVmplYWY3enFXVTBobmtYV0REcFhsckRFU3lRblEzd0dVMWtGeHpsQ3o3cnNyQUJYYmNnNFlXbERXTnVF?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:07:31+00:00", "published_display": "24 Apr 2025 17:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9kZlVsenJZV1NRZFJhTmZUQmZnLUxtQ09uNDdFM3BqTV9Nd3Y4dDFrUjNKdmVDX1VWM0hpZ1NpUU15dVQ5Wnozc3FLZDZRZWJi?oc=5", "source_name": "CNN", "published_at": "2025-03-09T00:48:10+00:00", "published_display": "09 Mar 2025 00:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Qiagen stock holds steady as diagnostics demand shapes long term outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQelQ5VFNlelhIMTJsZk10QUwxRE5sNFBOdEVJVVdSdHVFaS03NjJTXzE1NUZxNUJVUDB1a1k2VFlpM3IzYjFxX3dkVFg5UkxfRGt1Nl8takZ6Y0NSLWFHRzlIeFFwVnhHYlktNUIzN3JGZlZ6OUxwQlo3T1ZGUVJ4T2tXMnlzUlA1UVpoMFFpVlhxTlZhUTRUVWI2WjZRZHFIRHp4R0MyZE53SWI1Tk9KRmg0T3c2QkhnWEw3dDFXZXFCNTVpdDJJWVBHQQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-14T09:00:58+00:00", "published_display": "14 Jul 2026 09:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Number of shareholders of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "The article concerns the number of shareholders for Advanced Biomed Inc. (NASDAQ: ADVB). It is a brief entry from TradingView, which also provides additional financial and market data, tools, and community features related to stock trading and analysis.", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/number-of-shareholders/", "source_name": "TradingView", "published_at": "2026-07-13T13:40:55", "published_display": "13 Jul 2026 13:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYXRxTGlQaFZybjJ5a2J0WHl5bXp5QTRPMS1vTG5XVUoyU3Z4ZlRiSnUtRTQ2TWF4dG9FSzkwYmRYcnhDZUFqXzVuSTdFVEg1eVU0TXBNS2k0V2xEdm9MR3lzNTlCMzN3UEpMNmppZTlfbEZRWGloRm84VjllY0dtTUNMM3pCZFdyVUlPaS1saXdOOU1OVzVDa29zRURQZXlsRVZ6M3pITWVVSmVyQXZpSXIwWGxyaWxQZ1VNRTgwRGo4RndMZEE2MERVZlQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-13T06:08:44+00:00", "published_display": "13 Jul 2026 06:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOT0p5UGpYTGw0d1loeEdBbndGeFltLXVyMWdtWFl1eXYydnhXancxcnpWMUJvN3Y0RWxFTmljekw4b3BERndMUUduUW8xQUY3TktkRV9TOS1PcHJmaFNrV01pVWkzQzJJbG9fWjhUN0FDS2Vqa3JmenB2ellkUHZiMl9DRkJBbUNKcm85RndRd2tkU1dMLU5rRl9CNVZPQ1p6T1VkOF9OTEZoVDJKNi0xVDRjajNXVTA0eFVVY0RrWXQwS2M?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-12T12:19:06+00:00", "published_display": "12 Jul 2026 12:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche stock holds steady as pharma giant leans on diagnostics and oncology strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPa0hsdjNPUWxBTFVtcXYyOUpSbnB0WnpoR1k5c1EyaFVPOXJmR0NROGpoazIwMC1FWFFiYmh4VGl5ZkZHbEFtNXNBalBIbTY5Q29aSXdNTkpiNEU4ZDdIZHJ2SjNoYjRqaHBLdUNSYTBieUhEdHBzc1V0UFQ3QkxPZ0s0d2pSWWhid3pOQW5uMUVHRmRpQmpCa0FkY2hrVHM4c2ViTFRWOWpLVkY2NWpBM0FuMkFDZWlUaG5ncWl4ckxNeENDMjhHWVpUSG8xUQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-11T08:31:21+00:00", "published_display": "11 Jul 2026 08:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "This article provides the \"Price to book forward\" for Advanced Biomed Inc. (NASDAQ: ADVB) as listed on TradingView. It indicates that the market was closed at the time of viewing, with no trades having occurred. The content primarily features navigation links and disclaimers rela", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T17:39:58", "published_display": "08 Jul 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Labcorp stock holds its business focus. Clinical diagnostics remain the core.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTEN6RDNESkFmZDlqelJTb2V5b2txajhDRHJVd3RmR01BT0VyVjdvdllJMEZtNzRkQ0VyekhNU2Z4V0Q3S29SWXBtTndrSHpmcGQ3TzRyZW8wXzI1NzVoV1UtT1JpbDJJMmo2TXdBNy1EX2NOVlgzZ1lERmlyYThrSmJIcGVrQkVJa3lJLTFRSV9EUWhocDc5cWU1MjFEVGxJRWtCVE8yQkloZHVCTGV0SjVucktQSEJUSVJTZzdhUGFwVnVNNnA4Zg?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-08T09:51:39+00:00", "published_display": "08 Jul 2026 09:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "This article briefly mentions the \"Price to earnings forward\" metric for Advanced Biomed Inc. (NASDAQ: ADVB). It appears to be a stub or a section from a financial data platform, providing minimal direct information beyond the company name and stock ticker.", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-08T04:11:20", "published_display": "08 Jul 2026 04:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "The article focuses on the \"Price to sales forward\" metric for Advanced Biomed Inc. (NASDAQ: ADVB). It appears to be a stub or a section of a larger financial analysis tool, likely from TradingView, providing only a heading for this specific financial data point. No actual values", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T23:10:21", "published_display": "06 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Advanced Biomed Inc. \u2013 NASDAQ:ADVB", "summary": "This article provides financial data for Advanced Biomed Inc. (NASDAQ: ADVB), focusing on its enterprise value to EBIT forward. It indicates that the market was closed at the time of publication with no trades, and the content is primarily a data placeholder from TradingView.", "url": "https://www.tradingview.com/symbols/NASDAQ-ADVB/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-07-06T20:40:35", "published_display": "06 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Labcorp stock holds steady as investors watch the next filing cycle", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQNWV5dmpPWEZCYU5NSU0xbHNGMnp5LVYzT05raVVRblI2UF9nZHBGSVZlSkRORVNEVkltRkFXdEtMWnhkaDVLUWFfdVZIak1xSlZMZTZDbldvQ0dnYm9ZenF5elVOUjR6dDlCakFXOXh0bERqeTNHRzdkNHQzZmdGaU9uR0ktZEhBYm9jNTB1VExfVktFal82c1ZKcnBLQVJ3WkwzWVQtRWk3Y3liMGt6cU1SNThsX2o4a1NsZVk1UDVmLW40?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-07-04T08:31:51+00:00", "published_display": "04 Jul 2026 08:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (NASDAQ: ADVB) investors approve all 2026 meeting proposals", "summary": "Advanced Biomed Inc. (NASDAQ: ADVB) stockholders approved all five proposals at their annual meeting on June 30, 2026. These approvals included the election of five directors, a non-binding endorsement of executive compensation, annual advisory votes on pay, and the ratification ", "url": "https://www.stocktitan.net/sec-filings/ADVB/8-k-advanced-biomed-inc-reports-material-event-8ec3f8197919.html", "source_name": "Stock Titan", "published_at": "2026-07-02T08:41:03", "published_display": "02 Jul 2026 08:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. 8-K Filing: Company Details, Emerging Growth Status, and Nasdaq Listing for 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNcXVEOVZHZzlYekItZ21IRHQyTElZR25OcmY2NFhBZjlFSUI1aUJXekNPQVdzV2VkMnVrWFBRblVtZzN2amhYUFc5aUZxU1hraU1FUWdTYW5wejNTLU0xU3VvZjUxQ0ZucDRuaFhTU2xJV0Zzd3BUMDRFQW1QQ0MwR3BDZG5Dbi1uQTdlRGVsSl9hcGxSdXRoV09FSlA0T2EwVXplTGFKSFVQam1xMTdWMGVHVzExRkpGendPMWdyUzJsa0oweVM4cGRMbDJHWkJIdk52cg?oc=5", "source_name": "Minichart", "published_at": "2026-07-02T00:57:00+00:00", "published_display": "02 Jul 2026 00:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADVB - Advanced Biomed Inc Earnings", "summary": "This article provides a detailed financial overview of Advanced Biomed Inc (ADVB), including its last close price, market capitalization, earnings per share, and other key financial ratios and performance metrics. It lists short interest, insider and institutional ownership, prof", "url": "https://finviz.com/stock?t=ADVB&ty=ea&p=d&b=1", "source_name": "Finviz", "published_at": "2026-07-02T00:39:26", "published_display": "02 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (NASDAQ: ADVB) selling Taiwan R&D subsidiary for $490K", "summary": "Advanced Biomed Inc. (NASDAQ: ADVB) is selling its wholly-owned Taiwan R&D subsidiary, which focuses on biomedical research and development and the A+PerfusC 3D cell culture platform, for $490,000 to an unrelated third party. The transaction, reported in an 8-K filing, is expecte", "url": "https://www.stocktitan.net/sec-filings/ADVB/8-k-advanced-biomed-inc-reports-material-event-6540cd9f5d95.html", "source_name": "Stock Titan", "published_at": "2026-07-01T20:38:59", "published_display": "01 Jul 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed - To Sell Taiwan Subsidiary For $490,000 - SEC Filing", "summary": "Advanced Biomed (ADVB) has announced its intention to sell its Taiwan subsidiary for $490,000, according to a recent SEC filing. This information was reported by Refinitiv.", "url": "https://www.tradingview.com/news/reuters.com,2026:newsml_FWN4320WI:0-advanced-biomed-to-sell-taiwan-subsidiary-for-490-000-sec-filing/", "source_name": "TradingView", "published_at": "2026-07-01T08:39:00", "published_display": "01 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed to Divest Taiwan Subsidiary for $490,000; Closing Expected Within Three Months", "summary": "Advanced Biomed (ADVB) has entered into a Share Purchase Agreement to sell its Taiwan subsidiary for $490,000 to an unrelated third party. This divestiture includes its biomedical R&D operations and the A+PerfusC 3D cell culture platform. The move is aimed at refocusing the compa", "url": "https://www.tradingview.com/news/tradingview:07d989e53c9ff:0-advanced-biomed-to-divest-taiwan-subsidiary-for-490-000-closing-expected-within-three-months/", "source_name": "TradingView", "published_at": "2026-07-01T08:38:59", "published_display": "01 Jul 2026 08:38", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. Sells Taiwan Subsidiary for $490,000 in Share Purchase Agreement \u2013 Nasdaq: ADVB 8-K Filing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQWHdxYkQ2ckNRUTJnVUxWdTdzRzc1Tk1zdWxZRVNxM2VoemdYdm9TdXhJTjlHb2p2WlhKMlhLbVBLQW95ckNPa3BjVHFmem16RzlXTkRSZ2Z2VFpjdkI2TUJkUmdqWW5GLUtBbzdQYzVacWpVVEh6M2ZJNkpZWlhEV1dCRVdxc3lDR0FUSnBwanhMbjVTRTI0a2tTcU1BRjRNeTRVLU9SNTBIRTRXNTZkazlES0Z3alRkcGNzMGw0dHJ1em1GZE9SWmQwQlNIa2J6NTgzTDhmdDNnYmNYVGdB?oc=5", "source_name": "Minichart", "published_at": "2026-07-01T00:37:00+00:00", "published_display": "01 Jul 2026 00:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed | 10-Q: Q2 2026 Earnings Report", "summary": "This document is the 10-Q filing for Advanced Biomed's Q2 2026 earnings report. Further details about the financial performance for the quarter would be contained within the omitted content of this document. It serves as an official report to the SEC regarding the company's finan", "url": "https://www.moomoo.com/news/notice/306495190/advanced-biomed-10-q-q2-2026-earnings-report", "source_name": "Moomoo", "published_at": "2026-06-28T21:39:27", "published_display": "28 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Miaozhu Zhao entered into a Share Purchase Agreement to acquire Advanced Biomed Inc. from Advanced Biomed Inc. for $0.49 million.", "summary": "Miaozhu Zhao has entered into a Share Purchase Agreement to acquire Advanced Biomed Inc. for $0.49 million. The transaction is expected to be completed within three months from the agreement date of June 30, 2026. This acquisition involves a cash consideration paid towards the co", "url": "https://www.marketscreener.com/news/miaozhu-zhao-entered-into-a-share-purchase-agreement-to-acquire-advanced-biomed-inc-from-advanced-b-ce7f5edede80f52c?utm_source=copy&utm_medium=social&utm_campaign=share", "source_name": "marketscreener.com", "published_at": "2026-06-28T00:10:00", "published_display": "28 Jun 2026 00:10", "sentiment": "positive", "sentiment_pct": 58, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Agilent (A) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOQ3dIcEY1SVlJRzRVdm1YbDVMRTdody00UzB0OUhFQVhvenJBNERmNDlBbmZMMEZETzJaeVZfekJvYm9lYkVTdl8tbllZbUcxN1poZmFqX0I2ZXFzUE8zdV9TWlFUSXJUbkhDMFoxOW43amQyX1NzanNIZHI3YVFaZ1VkX1NqLTE0X3REem5paUVEc2dUMzJWSUtLVFhybm8?oc=5", "source_name": "TradingView", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Advanced Biomed Inc (ADVB), detailing its support, resistance, and key technical indicators. It presents a summary of various indicators like MACD, RSI, KDJ, and Moving Averages, which collectively suggest a \"Sell\" signal for the stoc", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/technical", "source_name": "TradingKey", "published_at": "2026-06-23T07:10:32", "published_display": "23 Jun 2026 07:10", "sentiment": "negative", "sentiment_pct": 37, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Labcorp Stock - Analyst and consensus view at the start of the week", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOcFVnd0dMT1ZYZFNld2dWaFF1T0Nic0dhemw1RmgyT2lmNlNJcmJWaDJyMVBfdXZsdHdObTRtQ2VkR25wMDBFSGk3c1lhLVZUVjB0MVU3eFJEM1V4OEZibmlRdTh0aTJNS3gtUURqV1RRRU5PN0lKandzUG1WYUYtTGpPS1VqMEF4U3MxTS13RGtzY2VuaXY0U0IwcUVYR2lkTzRfRmU4LWFyMDF5SGtvM2xjYkdKaWphLUlnTERLa1FkUQ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thermo Fisher Stock - Analyst consensus and Sunday background", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPVmxRNF9RX1BLajBmaXpRTU0wWWJOYUJKQWJmQWNHMnBaZ2EzQTBiUV9jVWgwT05WMlhDQUhCeXFwQnhHTjIxRjRzekpQbDBBMktiUjlqaTVlVHA4M3I5WnRPQUNSREs4MGs0MXFnb2VXVVF0djZjR3VMaEtsV3VJbzVONEp4eXl0NGRsWkQ2REtLSy1pbEVnSS13UXV6MHBEcjduTGE2cDNhZUFCQ3pEY1VXbE5wc0RIOWc?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-21T07:00:00+00:00", "published_display": "21 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Danaher Stock - long-term strategy in life sciences", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQTHdqczJiTzgxU2VwYnowLXhoanpKY0ZWX0dvMHF0OHc0NmJnREJPNmRCOTFNVUhjWkY2RTdaUklONUpxRC1qaG9rMG9Jbi1vTkhTM3NzbUljYUstUFdwejEtZWhMd2Y1UVZ1azRqTGpRbVM5SFZ4RENHeUdWZ3Y0NDdQWjd0czhPaHZ3Si1CSjQ2NlpOdWM0V19RUUw5dGV5a2ZSaklsbi1yc1pJ?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Stock - Analyst targets, sector review and weekly recap", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONXVEeDZuTjZDaXh0dnlqY0NPTENZX0c4cFBxSDV3UWh1NC1XMU9ialR4Wk5TbnlpRVpXU05EVENEYjAtcGpoZmR2TVhLandUM0tIS2V4Rmk0dDZJMk44bm9tbl9SRUwtcGNLOXBGOGp4WlNpeE1aY0ZwRDdEZzB2NDhhUXFCV0p1MFB2djBnaDdfREtqMmhHcTFFMHIwcy1qOURxR2c2QTQzTkNsczZqbklmb0h2WlE5OE51cUlZU0VyY2ZMeUpHVw?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-19T16:09:41+00:00", "published_display": "19 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bachem Stock - Analyst consensus and pipeline focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPejRJd3VQMzAtWnQwMUFQcnVfaEtOLThKODlKYjVITHRmNlh5Wi05T2xNWDQ0Q0piSkMydFcxaUpjWHJCc080LU1iZjEwaWxnX1RRYkFqX2tFdXQ1N0pqcWRKT1BQcmdtTkN1R2tDRlVmWjEzMG5kYjllQmpFN3pvT2JaRzNYVlVmd085SmlNNVpmaDBuU0lnMEUxOHdpTTlvTkpCcWk1SEp3MWZD?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-18T20:19:53+00:00", "published_display": "18 Jun 2026 20:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Institutional Confidence", "summary": "This article provides details on the institutional confidence in Advanced Biomed Inc (ADVB), including shareholder activity and the number of shares held by key individuals and firms. It shows that while some individual holders maintain significant positions, institutional holder", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T11:40:43", "published_display": "18 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a brief overview of Advanced Biomed Inc (ADVB) valuation metrics, including its current stock price, market cap, and P/E TTM. It notes that key valuation data such as P/E, P/B, P/S, and P/CF have not yet been disclosed by the company. The page appears to be ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T11:40:43", "published_display": "18 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Advanced Biomed Inc (ADVB), focusing on future EPS and revenue growth estimates. It notes that relevant data for financial forecasting, including EPS, revenue, net profit, and EBIT, has not yet been disclosed by the company. The info", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T11:40:43", "published_display": "18 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides a detailed historical overview of dividends and stock splits for Advanced Biomed Inc (ADVB). It notes that the company has not distributed any dividends in the past five years and lists one upcoming stock split event: a 20-for-1 merger scheduled for January ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T02:39:47", "published_display": "18 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc (ADVB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey reports on Advanced Biomed Inc (ADVB) and its revenue breakdown. However, it notes that key relevant data regarding business segments, regional revenue, and profit contribution have not yet been disclosed by the company. The page provides basic stock ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-advb/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T21:39:47", "published_display": "17 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (NASDAQ: ADVB) details 2026 votes and AI-focused acquisition", "summary": "Advanced Biomed (NASDAQ: ADVB) has detailed the agenda for its June 30, 2026, annual shareholder meeting, which includes electing directors, approving executive compensation, and ratifying auditors. The company highlighted recent strategic changes, including the appointment of Xi", "url": "https://www.stocktitan.net/sec-filings/ADVB/def-14a-advanced-biomed-inc-definitive-proxy-statement-c4f193386b1e.html", "source_name": "Stock Titan", "published_at": "2026-06-04T21:39:28", "published_display": "04 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Stock Inches Up Before Nasdaq Opens As AI Pivot Faces Its First Real Tests", "summary": "Advanced Biomed Inc. (NASDAQ:ADVBI) saw its shares rise before the Nasdaq session opened on Wednesday, following an announcement of a strategic pivot from life sciences to AI development. The company recently acquired Acellent Technologies (Hong Kong) and appointed Xiaomin Chen a", "url": "https://www.bez-kabli.pl/advanced-biomed-stock-inches-up-before-nasdaq-opens-as-ai-pivot-faces-its-first-real-tests/", "source_name": "Bez Kabli", "published_at": "2026-06-03T07:14:00", "published_display": "03 Jun 2026 07:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Company Profile & Introduction", "summary": "This document provides a company profile and introduction for Advanced Biomed. It details key information about the company's operations and objectives within the biomedical sector. The report aims to give a comprehensive overview for stakeholders interested in the company's back", "url": "https://www.moomoo.com/stock/ADVB-US/company?chain_id=Name1K9-3FXPhg.1l04rc0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A107,%22f%22%3A%22www.moomoo.com%2Fetfs%2FSGOL-US%22%7D", "source_name": "Moomoo", "published_at": "2026-06-02T13:09:32", "published_display": "02 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed(ADVB) Stock Options Chain | Quotes & News", "summary": "This page from Moomoo provides detailed stock information for Advanced Biomed (ADVB), including its options chain, real-time quotes, and key financial data. It also lists market insights and trending ETFs, along with legal disclosures regarding the risks of investing and options ", "url": "https://www.moomoo.com/stock/ADVB-US/options-chain?chain_id=Name1K9-3FXPhg.1l04rc0&global_content=%7B%22promote_id%22%3A13764,%22sub_promote_id%22%3A107,%22f%22%3A%22www.moomoo.com%2Fetfs%2FSGOL-US%22%7D", "source_name": "Moomoo", "published_at": "2026-05-30T09:10:49", "published_display": "30 May 2026 09:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADVB - Advanced Biomed Inc Stock Price and Quote", "summary": "This article provides a detailed overview of Advanced Biomed Inc (ADVB) stock, including its latest close price, key financial metrics, performance indicators, and recent news announcements. It covers financial data like market cap, income, P/E ratio, and insider ownership, along", "url": "https://finviz.com/stock?t=ADVB", "source_name": "Finviz", "published_at": "2026-05-29T19:41:05", "published_display": "29 May 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADVB Stock Chart | ADVANCED BIOMED INC (NASDAQ:ADVB)", "summary": "This page provides a stock chart for ADVANCED BIOMED INC (NASDAQ:ADVB), displaying its current stock price and recent performance. Users can view daily, weekly, or monthly charts with various display options. The site offers tools for technical and fundamental analysis, along wit", "url": "https://www.chartmill.com/stock/quote/ADVB/stock-chart", "source_name": "ChartMill", "published_at": "2026-05-29T19:39:54", "published_display": "29 May 2026 19:39", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (ADVB) Earnings Date and Reports 2026", "summary": "Advanced Biomed (ADVB) announced its Q3 2026 earnings on May 15, 2026, reporting an EPS of -$0.38 against a consensus estimate of -$0.38. The company currently has a trailing EPS of $4.82 and a P/E Ratio of 0.82. Investors can sign up for alerts to stay updated on future earnings", "url": "https://www.marketbeat.com/stocks/NASDAQ/ADVB/earnings/", "source_name": "MarketBeat", "published_at": "2026-05-22T16:10:55", "published_display": "22 May 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. 10-Q Summary: Net income $5.98M, EPS $5.21\u2014 10-Q Summary", "summary": "Advanced Biomed Inc. reported a significant improvement in its financial performance for the nine months ended March 31, 2026, with a net income of $5.98M and diluted EPS of $5.21, compared to a net loss in the prior year. The company has made progress in product development and ", "url": "https://www.tradingview.com/news/tradingview:77fa167d93e9d:0-advanced-biomed-inc-10-q-summary-net-income-5-98m-eps-5-21-10-q-summary/", "source_name": "TradingView", "published_at": "2026-05-15T13:38:55", "published_display": "15 May 2026 13:38", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Thermo Fisher Scientific stock (US8835561023): Q1 earnings beat with EPS of $5.44", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPbmxEX0RGdkI4NjVZUmItT1hobEdHaFl6dUVwQm01aGRIWW5zTnpWbUY5bVpPQWF1OW9OVVczMy1ReWdxTHJ3RXktOEdNY3lIUjdhUnV4enY0aTJVN2VWX01CbW9qWU51dDFRU1g1c21MU0c4MHBCYnBiZ00xeGRvVmkxVjdWSk8xeFhrRnpuek05azZRT1Z0bV8ya1Mzd0l4bHp0MHF4V1pzelVNTkVXVTVBVE8xeW9saElxTzdzbndfTEhEcjFr?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TWST Stock Forecast: Anticipated Revenue of $438.75M with Strong Margins", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQTTE2UVJHTkZNZFNYQ3NWeDlZdksxUG9nU0ZSVkFQVUZTZUU5QmNnZkJOYkd2TkVybjc4MHFCcXcyNWV4b3NDRnViOVVDc0RxSEM4MUN0NDNzTnctLTBsWkt1SFdBaUZfY0tYeFBHRXBpYlRzMHEwRGlYelRqU0V4cEhRU2VhSVh2dzRtaE9Ebi15bUd0Q0RNclRVN1ExYWttOUtnVnVfYUY3bjNlMUR6WDFXUHN0U2FWZV93Yw?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. completed the acquisition of Acellent Technologies (Hong Kong) Co. Limited from Xiaomin Chen.", "summary": "Advanced Biomed Inc. (NasdaqCM:ADVB) has completed the acquisition of Acellent Technologies (Hong Kong) Co. Limited from Xiaomin Chen for $1.2 million. The acquisition, which was conditioned on due diligence and regulatory approvals, was finalized on April 30, 2026. Advanced Biom", "url": "https://www.marketscreener.com/news/advanced-biomed-inc-completed-the-acquisition-of-acellent-technologies-hong-kong-co-limited-from-ce7f5bdbda8bf027", "source_name": "www.marketscreener.com", "published_at": "2026-05-03T22:11:13", "published_display": "03 May 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Completes AI Acquisition and Leadership Transition", "summary": "Advanced Biomed Inc. (ADVB) has acquired Acellent Technologies (Hong Kong) Co. Limited for $1.08 million in an all-stock deal, pivoting its business from life sciences to AI for financial markets. This strategic shift includes the departure of CEO Yi Lu and the appointment of Xia", "url": "https://www.tipranks.com/news/company-announcements/advanced-biomed-completes-ai-acquisition-and-leadership-transition", "source_name": "TipRanks", "published_at": "2026-05-01T22:40:24", "published_display": "01 May 2026 22:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ADVB Stock Soars Amid Strong Financial Performance and Strategic Milestones", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPMFdOLWtVQjcyRDB2U0o4WTVxTzNKaWJJNmVaUmRWV3NFRldUYVJqaE0xNldBU0FmWjVINjFna3h5RnBOa0JZbWZYd21XaUowWDF4eG9lV2ROc2M1UUo3RGNLR1RKMllOMXAtMmstQ0hpdmdzYkxnVHhhRnBwNTJoeg?oc=5", "source_name": "timothysykes.com", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Natera's Recent Stock Action", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxQdUptOV9abnB2R3daZE82Sm16ZnBLY3I2bWo1Nk9ZZ3M0U2FJYUQyNFFnM09UQzBSaWQ4c0tnSnp1S01Wa00tYnhfbGNoc1BtcXh2MWhYY09zZG5zSkJsSWFaaTZZSnJ4UC1YLWgzRTlqaXh5MU5vOG9ybUpWTG14eS11Z2Q?oc=5", "source_name": "Kavout | AI", "published_at": "2026-03-17T04:42:02+00:00", "published_display": "17 Mar 2026 04:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed Inc. Announces 1 for 20 Share Consolidation", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxQckNfUXgtNEF6THBXdE5RVUhrQkJTeTFzYWxnbHdZMWRNSWx2OWg3MExIWmZuaDFvekJXc3dFNVlleXo3Q29JTFB6VkdSRkRteElnZVhrdGE3a09NbkFoYXVhbEw1X2pNMXZoa1BTUHFIY2YxOV9rbFZXdlpOcU1IbUhDMA?oc=5", "source_name": "Market source", "published_at": "2026-02-18T08:00:00+00:00", "published_display": "18 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (ADVB) Stock Forecast and Price Target 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE9vVWx0bDdoNHlRZDRIQkZHSml3Q05sYUhQVDJBVEZ2MDJUVFF6OW5HYjdSYU5fbmRCT0J0WHJpN05kazJkN2Y0bUFsVU83MjNRbzloaWluVjRMT21FU2FyWU9OM3J2dw?oc=5", "source_name": "MarketBeat", "published_at": "2026-01-28T04:32:08+00:00", "published_display": "28 Jan 2026 04:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Advanced Biomed (ADVB) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE1ld0dpbHBDbDM0VEJlaS1hdUNjRzNCcmh0TVd1VVRhXzBLVHpmVWJyWTdFNDFSa3Ita1Rxb3kzUkRsWVAxTkRHUGZjbjFDTzVOeWJvUDBhcF9idw?oc=5", "source_name": "MarketBeat", "published_at": "2026-01-28T04:32:07+00:00", "published_display": "28 Jan 2026 04:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mainz Biomed NV (MYNZ) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1tRFFLUWNOZnpFTzhEazgyejF6dWszZTFBaTd4Ujh2QWxzRUczYUhIT0lZQUlOR3RqSnJrb2h3OUYxYk50V3A4NkllMGQ0SnE0dkRB?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:00:43+00:00", "published_display": "25 Apr 2025 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "bioAffinity Tech (BIAF) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBuOHNESDRoUTBXSmRReFY0aUwxZ1FRa1REcXJkMmVqbFRYN1d6Q216M3NMRFluQ200eHRSTk81ZWdkajZPLWVEaEFSMFlHRmxGLUZr?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T20:37:30+00:00", "published_display": "24 Apr 2025 20:37", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "XWELL (XWEL) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5Yd2VxUDJhMHRobmFmV0pUVmplYWY3enFXVTBobmtYV0REcFhsckRFU3lRblEzd0dVMWtGeHpsQ3o3cnNyQUJYYmNnNFlXbERXTnVF?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:07:31+00:00", "published_display": "24 Apr 2025 17:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE9kZlVsenJZV1NRZFJhTmZUQmZnLUxtQ09uNDdFM3BqTV9Nd3Y4dDFrUjNKdmVDX1VWM0hpZ1NpUU15dVQ5Wnozc3FLZDZRZWJi?oc=5", "source_name": "CNN", "published_at": "2025-03-09T00:48:10+00:00", "published_display": "09 Mar 2025 00:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 83, "total_relevant": 57, "sentiment_summary": {"positive": 13, "negative": 2, "neutral": 42, "score": 53, "total": 57, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 17.05, "count": 31}, {"event": "earnings", "label": "Earnings", "weight": 6.95, "count": 12}, {"event": "deals", "label": "Deals and strategy", "weight": 2.75, "count": 5}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "guidance", "label": "Guidance", "weight": 1.65, "count": 3}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.1, "count": 2}], "positive_events": 13, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 5.16, "latest_week": "2026-07-10", "one_week_move": 3.4, "four_week_move": 14.7, "twelve_week_move": 7.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.001604, "market_dynamics_buy_signal": false, "relative_strength": -36.218022, "fair_value_gap": -65.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 45.7522, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.4% over one week, +14.7% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 61, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Ad Hoc News", "count": 12}, {"label": "TradingView", "count": 9}, {"label": "Stock Titan", "count": 6}, {"label": "TradingKey", "count": 6}, {"label": "Moomoo", "count": 3}, {"label": "MarketBeat", "count": 3}, {"label": "Minichart", "count": 2}, {"label": "Finviz", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 57}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 31}, {"label": "Earnings", "count": 12}, {"label": "Deals and strategy", "count": 5}, {"label": "Analyst action", "count": 4}, {"label": "Guidance", "count": 3}, {"label": "Macro sensitivity", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "57", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.4% over one week, +14.7% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Qiagen stock holds steady as diagnostics demand shapes long term outlook"}], "updated_at": "2026-07-16T18:58:37.101583+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}